CVE-2020-16247
HIGHCVSS 7.1/10EPSS 0.34%
Last modified
CVE-2020-16247 is a high-severity vulnerability rated 7.1/10 on the CVSS scale. Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, exposes a resource to the wrong control sphere, providing unintended actors with inappropriate access to the resource.. EPSS estimates a 0.34% chance of exploitation in the next 30 days.
Description
Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, exposes a resource to the wrong control sphere, providing unintended actors with inappropriate access to the resource.
Metrics
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Philips | Clinical Collaboration Platform | <= 12.2.1 |
References
- https://us-cert.cisa.gov/ics/advisories/icsma-20-261-01Third Party Advisory, US Government Resource
- https://us-cert.cisa.gov/ics/advisories/icsma-20-261-01Third Party Advisory, US Government Resource
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2020-16247?
Philips Clinical Collaboration Platform, Versions 12.2.1 and prior,
exposes a resource to the wrong control sphere, providing unintended actors with inappropriate access to the resource.
How severe is CVE-2020-16247?
CVE-2020-16247 has a CVSS score of 7.1/10 (HIGH severity). The EPSS model estimates a 0.34% probability of exploitation in the next 30 days.
How do I fix CVE-2020-16247?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2020-16247?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST